|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.100 EUR | 0.00% |
|
0.00% | -7.79% |
| 02-26 | EARNINGS AND TRADING: Connecting Excellence hails record January fees | AN |
| 02-26 | Malin Corporation says CEO Fiona Dunlevy will leave Malin end of May | RE |
| Market Cap | 30.78M 35.44M 28.58M 26.36M 49.65M 3.38B 50.55M 338M 132M 1.68B 133M 130M 5.65B | P/E 2024 * |
-
| P/E 2025 | -8.37x |
|---|---|---|---|---|---|
| Enterprise Value | 17.88M 20.58M 16.6M 15.31M 28.84M 1.97B 29.37M 197M 76.96M 976M 77.3M 75.61M 3.28B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
63.83% | Yield 2024 * |
-
| Yield 2025 | - |
| Current month | -4.70% | ||
| 1 month | -4.70% | ||
| 3 months | -10.69% | ||
| 6 months | -11.25% | ||
| Current year | -7.79% |
| 1 week | 7.1 |  | 7.1 |
| 1 month | 7.1 | | 7.25 |
| Current year | 7 | | 8.45 |
| 1 year | 7 | | 9.3 |
| 3 years | 3.84 | | 10.4 |
| 5 years | 3.59 | | 10.4 |
| 10 years | 1.4 | | 14.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Stafford
DFI | Director of Finance/CFO | 56 | 2022-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
William Daniel
CHM | Chairman | 73 | 2019-08-01 |
| Director/Board Member | 67 | 2018-07-15 | |
Rudy Mareel
BRD | Director/Board Member | 63 | 2018-07-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/28/25 | Fiscal year | Chief Executive Officer | 5,746 | 0.1328% | ||
| 4/7/25 | Sell | Director | 11,075 | 0.2560% | ||
| 4/7/25 | Sell | Chief Executive Officer | 17,780 | 0.4110% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -11.25% | +59.19% | 35.44M | |
| -4.55% | -2.61% | +51.95% | +151.91% | 1,030B | |
| -3.66% | -1.33% | +52.95% | +46.62% | 617B | |
| -2.24% | +0.19% | +35.97% | +70.64% | 455B | |
| +1.17% | +1.12% | +36.13% | +31.18% | 350B | |
| +0.87% | -0.69% | +33.42% | +40.48% | 299B | |
| +0.75% | +0.25% | +10.63% | +15.03% | 265B | |
| +0.36% | +3.31% | +1.82% | -37.38% | 225B | |
| 0.00% | +4.34% | +28.63% | +64.00% | 209B | |
| -1.09% | +0.32% | +14.40% | +70.80% | 163B | |
| Average | -0.33% | +4.35% | +25.46% | +51.25% | 361.27B | |
| Weighted average by Cap. | -0.58% | +4.87% | +37.84% | +72.19% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | - | -6.9M -7.94M -6.41M -5.91M -11.13M -758M -11.33M -75.86M -29.7M -377M -29.83M -29.18M -1.27B |
| Net Debt | -62.1M -71.49M -57.67M -53.18M -100M -6.83B -102M -683M -267M -3.39B -268M -263M -11.4B | -12.9M -14.85M -11.98M -11.05M -20.81M -1.42B -21.19M -142M -55.53M -704M -55.77M -54.55M -2.37B |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-30 | €7.100 | 0.00% | 0 |
| 26-07-29 | €7.100 | 0.00% | 0 |
| 26-07-28 | €7.100 | 0.00% | 1 |
| 26-07-27 | €7.100 | 0.00% | 0 |
| 26-07-24 | €7.100 | 0.00% | 1 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.100EUR
Average target price
15.50EUR
Spread / Average Target
+118.31%
- Stock Market
- Stocks
- MLC Stock
Select your edition
All financial news and data tailored to specific country editions
